Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « AbsEn.i » - entrée « than »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
thames < than < thanks  Facettes :

List of bibliographic references indexed by than

Number of relevant bibliographic references: 425.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000016 (2020) M. SilbersteinVitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
000020 (2020) Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report.
000044 (2020) Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments
000076 (2020) Philip George [Nouvelle-Zélande] ; Nathaniel Dasyam [Nouvelle-Zélande] ; Giulia Giunti [Nouvelle-Zélande] ; Brigitta Mester [Nouvelle-Zélande] ; Evelyn Bauer [Nouvelle-Zélande] ; Bethany Andrews [Nouvelle-Zélande] ; Travis Perera [Nouvelle-Zélande] ; Tess Ostapowicz [Nouvelle-Zélande] ; Chris Frampton [Nouvelle-Zélande] ; Peng Li [République populaire de Chine] ; David Ritchie [Australie] ; Catherine M. Bollard [États-Unis] ; Ian F. Hermans [Nouvelle-Zélande] ; Robert Weinkove [Nouvelle-Zélande]Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE)
000086 (2020) Christine Brostjan ; Rudolf OehlerThe role of neutrophil death in chronic inflammation and cancer
000129 (2020) Mariano Mora-Pereira [États-Unis] ; Eva M. Abarca [États-Unis] ; Sue Duran [États-Unis] ; William Ravis [États-Unis] ; Richard J. Mcmullen [États-Unis] ; Britta M. Fischer [États-Unis] ; Yann-Huei Phillip Lee [États-Unis] ; Anne A. Wooldridge [États-Unis]Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies
000144 (2020) Wolfgang F. Richter [Suisse] ; Hans-Peter Grimm [Suisse] ; Marie-Hélène Gouy [Suisse] ; Susi S Gaard [Danemark] ; Caroline Kreuzer [Suisse] ; Uwe Wessels [Allemagne] ; Dragomir Draganov [Suisse] ; Chris Muenzer [Suisse] ; Tonio Hoche [Suisse]Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans.
000145 (2020) Yunze Li [République populaire de Chine] ; Yixin Yang [République populaire de Chine] ; Jinwan Guo [République populaire de Chine] ; Xuejiao Guo [République populaire de Chine] ; Zhiying Feng [République populaire de Chine] ; Xuli Zhao [République populaire de Chine]Spinal NF-kB upregulation contributes to hyperalgesia in a rat model of advanced osteoarthritis
000177 (2020) Kaveh Hajifathalian ; Srihari Mahadev ; Robert E. Schwartz ; Shawn Shah ; Kartik Sampath ; Felice Schnoll-Sussman ; Robert S. Brown Jr ; David Carr-Locke ; David E. Cohen ; Reem Z. SharaihaSARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant
000183 (2020) Ibai Los-Arcos [Espagne] ; Juan Aguilar-Company [Espagne] ; Isabel Ruiz-Camps [Espagne]Risk of infection associated with new therapies for lymphoproliferative syndromes.
000199 (2020) Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000208 (2020) Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie]Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
000222 (2020) Paul Emery [Royaume-Uni] ; Sarah Horton [Royaume-Uni] ; Raluca Bianca Dumitru [Royaume-Uni] ; Kamran Naraghi [Royaume-Uni] ; Désirée Van Der Heijde [Pays-Bas] ; Richard J. Wakefield [Royaume-Uni] ; Elizabeth M A. Hensor [Royaume-Uni] ; Maya H. Buch [Royaume-Uni]Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
000255 (2020) Domenico Umberto De Rose [Italie] ; Fiammetta Piersigilli [Italie, Belgique] ; Maria Paola Ronchetti [Italie] ; Alessandra Santisi [Italie] ; Iliana Bersani [Italie] ; Andrea Dotta [Italie] ; Olivier Danhaive [Belgique] ; Cinzia Auriti [Italie]Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far
000274 (2020) Meng Hsuan Kuo [Taïwan] ; Chih-Wei Tseng [Taïwan] ; Chi-Hui Lee [Taïwan] ; Chien-Hsueh Tung [Taïwan] ; Kuo-Chih Tseng [Taïwan] ; Ning-Sheng Lai [Taïwan]Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis
000299 (2020) Daniel H. Glaser [États-Unis] ; Christina Schutt [États-Unis] ; Kaila Schollaert-Fitch [États-Unis] ; Kathryn Torok [États-Unis]Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties
000302 (2020) Adriana Balduzzi [Italie] ; Erica Brivio [Italie, Pays-Bas] ; Attilio Rovelli [Italie] ; Carmelo Rizzari [Italie] ; Serena Gasperini [Italie] ; Maria Luisa Melzi [Italie] ; Valentino Conter [Italie] ; Andrea Biondi [Italie]Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
000348 (2020) Sisi Xie ; Shu Li ; Jing Tian ; Fen LiIguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
000352 (2020) Sakthi Rajendran [États-Unis] ; Florence Anquetil [États-Unis] ; Estefania Quesada-Masachs [États-Unis] ; Madeleine Graef [États-Unis] ; Nathaly Gonzalez [États-Unis] ; Sara Mcardle [États-Unis] ; Tiffany Chu [États-Unis] ; Lars Krogvold [Norvège] ; Knut Dahl-J Rgensen [Norvège] ; Matthias Von Herrath [États-Unis]IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes.
000359 (2020) Yanyan Han ; Takuro Igawa ; Kyohei Ogino ; Asami Nishikori ; Yuka Gion ; Tadashi Yoshino ; Yasuharu SatoHemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease
000370 (2020) Yi-Ming Chen [Taïwan] ; Wei-Ting Hung [Taïwan] ; Wan-Chun Chang [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Wen-Hung Chung [Taïwan] ; Joung-Liang Lan [Taïwan] ; Ning-Rong Gung [Taïwan] ; Yun-Shien Lee [Taïwan] ; Der-Yuan Chen [Taïwan] ; Shuen-Iu Hung [Taïwan]Genetic Association and Expression Correlation between Colony-Stimulating Factor 1 Gene Encoding M-CSF and Adult-Onset Still's Disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "than" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "than" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    than
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021